Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.4100 (-4.25%) ($5.3200 - $5.4900) on Thu. Feb. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.69% (three month average) | RSI | 55 | Latest Price | $5.4100(-4.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -1.9% a day on average for past five trading days. | Weekly Trend | EYES advances 2.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) IGOV(19%) SHY(18%) VIXM(12%) BNDX(11%) VXX(10%) | Factors Impacting EYES price | EYES will decline at least -2.845% in a week (0% probabilities). QQQ(-18%) XOP(-17%) XLK(-17%) IYT(-17%) XRT(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.845% (StdDev 5.69%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $5.59(-3.22%) | 10 Day Moving Average | $5.6(-3.39%) | 20 Day Moving Average | $5.27(2.66%) | To recent high | -25.8% | To recent low | 8% | Market Cap | $1.728b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |